Evidence-based treatment of Tourette’s disorder and chronic tic disorders

Joey Ka Yee Essoe, Marco A. Grados, Harvey S. Singer, Nicholas S. Myers, Joseph F. McGuire

Research output: Contribution to journalReview article

Abstract

Introduction: Chronic Tic Disorders and Tourette’s Disorder (collectively referred to as TD) are characterized by sudden, rapid, and repetitive motor movements or vocalizations called tics. Children, adolescents, and adults with TD often experience co-occurring psychiatric symptoms and impairments in multiple domains. As a result of tics and other symptoms, patients with TD can develop negative self-views, require considerable accommodations, and experience a poor quality of life. Therefore, the efficient and effective management of TD bears considerable importance. Areas covered: This expert review evaluated the empirical support for behavioral and pharmacological interventions based on the results of randomized controlled trials (RCTs). Behavioral interventions evaluated include habit reversal training (HRT), comprehensive behavioral intervention for tics (CBIT), and exposure response prevention (ERP). Reviewed pharmacological interventions included alpha-2 agonists, antipsychotics, and anticonvulsants. Expert opinion: This review identified several efficacious behavioral and pharmacological interventions for TD. However, several gaps in the management of TD include: (1) the access/availability of behavioral interventions, (2) novel and more efficacious treatment approaches, and (3) the development of more comprehensive interventions to manage TD. In order to advance the treatment of TD, additional research is necessary to efficiently, effectively, and comprehensively develop and evaluate new treatments for patients with TD.

Original languageEnglish (US)
Pages (from-to)1103-1115
Number of pages13
JournalExpert review of neurotherapeutics
Volume19
Issue number11
DOIs
StatePublished - Nov 2 2019

Fingerprint

Tic Disorders
Tics
Tourette Syndrome
Pharmacology
Expert Testimony
Anticonvulsants
Antipsychotic Agents
Habits
Psychiatry
Therapeutics
Randomized Controlled Trials
Quality of Life
Research

Keywords

  • behavior therapy
  • comprehensive behavioral intervention for tics
  • pharmacotherapy
  • randomized controlled trials
  • Tourette’s disorder

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Evidence-based treatment of Tourette’s disorder and chronic tic disorders. / Essoe, Joey Ka Yee; Grados, Marco A.; Singer, Harvey S.; Myers, Nicholas S.; McGuire, Joseph F.

In: Expert review of neurotherapeutics, Vol. 19, No. 11, 02.11.2019, p. 1103-1115.

Research output: Contribution to journalReview article

@article{5e10d567ac274cdbbf0f83389eee6ea4,
title = "Evidence-based treatment of Tourette’s disorder and chronic tic disorders",
abstract = "Introduction: Chronic Tic Disorders and Tourette’s Disorder (collectively referred to as TD) are characterized by sudden, rapid, and repetitive motor movements or vocalizations called tics. Children, adolescents, and adults with TD often experience co-occurring psychiatric symptoms and impairments in multiple domains. As a result of tics and other symptoms, patients with TD can develop negative self-views, require considerable accommodations, and experience a poor quality of life. Therefore, the efficient and effective management of TD bears considerable importance. Areas covered: This expert review evaluated the empirical support for behavioral and pharmacological interventions based on the results of randomized controlled trials (RCTs). Behavioral interventions evaluated include habit reversal training (HRT), comprehensive behavioral intervention for tics (CBIT), and exposure response prevention (ERP). Reviewed pharmacological interventions included alpha-2 agonists, antipsychotics, and anticonvulsants. Expert opinion: This review identified several efficacious behavioral and pharmacological interventions for TD. However, several gaps in the management of TD include: (1) the access/availability of behavioral interventions, (2) novel and more efficacious treatment approaches, and (3) the development of more comprehensive interventions to manage TD. In order to advance the treatment of TD, additional research is necessary to efficiently, effectively, and comprehensively develop and evaluate new treatments for patients with TD.",
keywords = "behavior therapy, comprehensive behavioral intervention for tics, pharmacotherapy, randomized controlled trials, Tourette’s disorder",
author = "Essoe, {Joey Ka Yee} and Grados, {Marco A.} and Singer, {Harvey S.} and Myers, {Nicholas S.} and McGuire, {Joseph F.}",
year = "2019",
month = "11",
day = "2",
doi = "10.1080/14737175.2019.1643236",
language = "English (US)",
volume = "19",
pages = "1103--1115",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - Evidence-based treatment of Tourette’s disorder and chronic tic disorders

AU - Essoe, Joey Ka Yee

AU - Grados, Marco A.

AU - Singer, Harvey S.

AU - Myers, Nicholas S.

AU - McGuire, Joseph F.

PY - 2019/11/2

Y1 - 2019/11/2

N2 - Introduction: Chronic Tic Disorders and Tourette’s Disorder (collectively referred to as TD) are characterized by sudden, rapid, and repetitive motor movements or vocalizations called tics. Children, adolescents, and adults with TD often experience co-occurring psychiatric symptoms and impairments in multiple domains. As a result of tics and other symptoms, patients with TD can develop negative self-views, require considerable accommodations, and experience a poor quality of life. Therefore, the efficient and effective management of TD bears considerable importance. Areas covered: This expert review evaluated the empirical support for behavioral and pharmacological interventions based on the results of randomized controlled trials (RCTs). Behavioral interventions evaluated include habit reversal training (HRT), comprehensive behavioral intervention for tics (CBIT), and exposure response prevention (ERP). Reviewed pharmacological interventions included alpha-2 agonists, antipsychotics, and anticonvulsants. Expert opinion: This review identified several efficacious behavioral and pharmacological interventions for TD. However, several gaps in the management of TD include: (1) the access/availability of behavioral interventions, (2) novel and more efficacious treatment approaches, and (3) the development of more comprehensive interventions to manage TD. In order to advance the treatment of TD, additional research is necessary to efficiently, effectively, and comprehensively develop and evaluate new treatments for patients with TD.

AB - Introduction: Chronic Tic Disorders and Tourette’s Disorder (collectively referred to as TD) are characterized by sudden, rapid, and repetitive motor movements or vocalizations called tics. Children, adolescents, and adults with TD often experience co-occurring psychiatric symptoms and impairments in multiple domains. As a result of tics and other symptoms, patients with TD can develop negative self-views, require considerable accommodations, and experience a poor quality of life. Therefore, the efficient and effective management of TD bears considerable importance. Areas covered: This expert review evaluated the empirical support for behavioral and pharmacological interventions based on the results of randomized controlled trials (RCTs). Behavioral interventions evaluated include habit reversal training (HRT), comprehensive behavioral intervention for tics (CBIT), and exposure response prevention (ERP). Reviewed pharmacological interventions included alpha-2 agonists, antipsychotics, and anticonvulsants. Expert opinion: This review identified several efficacious behavioral and pharmacological interventions for TD. However, several gaps in the management of TD include: (1) the access/availability of behavioral interventions, (2) novel and more efficacious treatment approaches, and (3) the development of more comprehensive interventions to manage TD. In order to advance the treatment of TD, additional research is necessary to efficiently, effectively, and comprehensively develop and evaluate new treatments for patients with TD.

KW - behavior therapy

KW - comprehensive behavioral intervention for tics

KW - pharmacotherapy

KW - randomized controlled trials

KW - Tourette’s disorder

UR - http://www.scopus.com/inward/record.url?scp=85073184677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073184677&partnerID=8YFLogxK

U2 - 10.1080/14737175.2019.1643236

DO - 10.1080/14737175.2019.1643236

M3 - Review article

C2 - 31295410

AN - SCOPUS:85073184677

VL - 19

SP - 1103

EP - 1115

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 11

ER -